Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines (Q82973963)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 December 2010

Language	Label	Description	Also known as
English	Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines	scientific article published on 22 December 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kohei Shitara

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Satoshi Yuki

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Motoki Yoshida

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Daisuke Takahari

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Setsuo Utsunomiya

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tomoya Yokota

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Yozo Sato

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Yoshitaka Inaba

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Masahiro Tajika

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hiroki Kawai

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hidekazu Yamaura

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mina Kato

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Kentaro Yamazaki

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Yoshito Komatsu

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Kei Muro

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

22 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

787-793

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174225%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a phase II single institution trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab plus irinotecan in heavily pretreated metastatic colorectal cancer progressing on irinotecan: MABEL Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab for the treatment of colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter Phase II study of cetuximab plus irinotecan in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin and fluoropyrimidines

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21174225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82973963&oldid=2234984632"